Valuation: Shanghai MicroPort Endovascular MedTech Co., Ltd.

Market Cap 1.09TCr 160.52Cr 140.41Cr 129.51Cr 119.62Cr 226.97Cr 15TCr 230.79Cr 1.55TCr 607.68Cr 7.54TCr 602.72Cr 589.6Cr 26TCr P/E 2026 *
17.3x
P/E 2027 * 15.2x
Enterprise Value 784.55Cr 115.71Cr 101.21Cr 93Cr 86Cr 163.6Cr 11TCr 166.35Cr 1.12TCr 438.03Cr 5.44TCr 434.45Cr 425Cr 19TCr EV / Sales 2026 *
4.63x
EV / Sales 2027 * 4.78x
Free-Float
57.4%
Yield 2026 *
3.54%
Yield 2027 * 3.23%
29/04 Microport Scientific says qtrly net profit attributable for Shanghai Microport Endovascular Medtech (Group) RMB154.8 mln RE
29/04 Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
30/03 Microport Scientific FY net profit attributable for Shanghai MicroPort Endovascular MedTech rmb563.3 million RE
27/02 Microport Scientific logs FY net profit attributable for Shanghai MicroPort Endovascular MedTech RMB563.2 mln RE
27/02 Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
29/25/29 Microport Scientific updates on 9-month results of Shanghai Microport Endovascular Medtech RE
29/25/29 Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
28/25/28 Tranche Update on Shanghai MicroPort Endovascular MedTech Co., Ltd.'s Equity Buyback Plan announced on October 29, 2024. CI
27/25/27 Shanghai MicroPort Endovascular MedTech Co., Ltd.'s Equity Buyback announced on October 29, 2024, has closed with 1,333,943 shares, representing 1.09% for CNY 140.1 million. CI
10/25/10 Tranche Update on Shanghai MicroPort Endovascular MedTech Co., Ltd.'s Equity Buyback Plan announced on October 29, 2024. CI
26/25/26 Microport Scientific says HY revenue of Shanghai MicroPort Endovascular MedTech RMB714.4 mln RE
26/25/26 Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
15/25/15 MicroPort Scientific Flags H1 Profit, Revenue Decline in MicroPort Endovascular Medtech; Shares Fall 1% MT
1 day+0.49%
1 week-3.87%
Current month+1.61%
1 month-3.10%
3 months-12.10%
6 months-8.50%
Current year-1.73%
1 week 88.17
Extreme 88.17
92.46
1 month 83.33
Extreme 83.33
94.27
Current year 83.33
Extreme 83.33
116
1 year 83.33
Extreme 83.33
124.3
3 years 78.62
Extreme 78.62
141.14
5 years 78.62
Extreme 78.62
266.45
10 years 67.79
Extreme 67.7852
322.15
Manager TitleAgeSince
Chief Executive Officer 45 15/07/2021
Director of Finance/CFO 46 28/10/2021
Chief Tech/Sci/R&D Officer 49 14/11/2025
Director TitleAgeSince
Chairman 51 31/12/2025
Director/Board Member 49 14/11/2025
Director/Board Member 40 30/03/2022
Change 5-day change 1-year change 3-year change Capi.($)
+0.49%-3.87%-6.10%-23.90% 160.52Cr
+0.82%+0.99%-15.32%+10.65% 13TCr
+0.79%+1.28%+2.82%-1.58% 1.29TCr
-1.52%+2.95%+47.11%+112.20% 896.56Cr
+4.14%-2.38%-48.62%-71.98% 397.65Cr
-0.47%-1.34%+20.55%+45.56% 269.84Cr
+0.61%-7.70%-14.75%-24.08% 174.47Cr
+0.47%+10.24%-60.26%-83.72% 149.14Cr
+2.10%+14.44%-24.33%-60.71% 148.22Cr
Average +0.83%+1.55%-10.99%-10.84% 1.79TCr
Weighted average by Cap. +0.75%+1.04%-11.02%+11.62%

Financials

2026 *2027 *
Net sales 169.59Cr 25Cr 22Cr 20Cr 19Cr 35Cr 2.39TCr 36Cr 241.1Cr 95Cr 1.18TCr 94Cr 92Cr 4.04TCr 181.46Cr 27Cr 23Cr 22Cr 20Cr 38Cr 2.55TCr 38Cr 257.98Cr 101.31Cr 1.26TCr 100.48Cr 98Cr 4.32TCr
Net income 64Cr 9.42Cr 8.24Cr 7.6Cr 7.02Cr 13Cr 898.87Cr 14Cr 91Cr 36Cr 442.81Cr 35Cr 35Cr 1.52TCr 73Cr 11Cr 9.38Cr 8.65Cr 7.99Cr 15Cr 1.02TCr 15Cr 103.39Cr 41Cr 503.93Cr 40Cr 39Cr 1.73TCr
Net Debt -303.86Cr -45Cr -39Cr -36Cr -33Cr -63Cr -4.27TCr -64Cr -432.01Cr -169.65Cr -2.11TCr -168.27Cr -164.61Cr -7.24TCr -220.59Cr -33Cr -28Cr -26Cr -24Cr -46Cr -3.1TCr -47Cr -313.61Cr -123.16Cr -1.53TCr -122.15Cr -119.49Cr -5.25TCr
Logo Shanghai MicroPort Endovascular MedTech Co., Ltd.
Shanghai MicroPort Endovascular MedTech Group Co Ltd is a China-based company primarily engaged in the research, development, production, and sales of interventional medical devices for the aorta and peripheral blood vessels. The Company's products are mainly categorized into aortic stents, peripheral vascular devices and others. The aortic stent products include thoracic aortic stent graft systems, abdominal aortic stent graft systems, and other surgical accessories. The peripheral vascular and other products mainly include intraoperative stent systems, peripheral arteries, peripheral veins, interventional oncology devices, and peripheral vascular surgical accessories. The Company conducts its businesses in domestic and overseas markets.
Employees
822
Date Price Change Volume
10/26/10 CN¥90.07 +0.49% 18,10,937
09/26/09 CN¥89.63 -0.21% 14,20,649
08/26/08 CN¥89.82 -1.01% 14,38,855
07/26/07 CN¥90.74 -2.17% 14,29,321
06/26/06 CN¥92.75 -1.01% 17,24,317
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
90.07CNY
Average target price
127.25CNY
Spread / Average Target
+41.28%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 688016 Stock